0001562180-23-006838.txt : 20230913 0001562180-23-006838.hdr.sgml : 20230913 20230913160228 ACCESSION NUMBER: 0001562180-23-006838 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230911 FILED AS OF DATE: 20230913 DATE AS OF CHANGE: 20230913 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Agresta Samuel CENTRAL INDEX KEY: 0001748961 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39634 FILM NUMBER: 231252667 MAIL ADDRESS: STREET 1: 784 MEMORIAL DR. CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Foghorn Therapeutics Inc. CENTRAL INDEX KEY: 0001822462 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 500 TECHNOLOGY SQUARE STREET 2: SUITE 700 CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-586-3100 MAIL ADDRESS: STREET 1: 500 TECHNOLOGY SQUARE STREET 2: SUITE 700 CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 primarydocument.xml PRIMARY DOCUMENT X0508 4 2023-09-11 true 0001822462 Foghorn Therapeutics Inc. FHTX 0001748961 Agresta Samuel 500 TECHNOLOGY SQUARE STE 700 CAMBRIDGE MA 02139 false true false false Chief Medical Officer false Stock Options (Right to buy) 16.63 2031-01-27 Common Stock 100000.00 100000.00 D Stock Options (Right to buy) 14.87 2032-01-25 Common Stock 125000.00 125000.00 D Stock Options (Right to buy) 8.77 2030-08-17 Common Stock 91891.00 91891.00 D Stock Options (Right to buy) 8.38 2033-01-25 Common Stock 60000.00 60000.00 D The option vested as to 25% of the underlying shares of common stock on January 28, 2022, and at a rate of 6.25% of the underlying shares thereafter on the first day of each calendar quarter. The option vested as to 25% of the underlying shares of common stock on January 26, 2023, and at a rate of 6.25% of the underlying shares thereafter on the first day of each calendar quarter. The option vested as to 25% of the underlying shares of common stock on August 17, 2021, and at a rate of 6.25% of the underlying shares thereafter on the first day of each calendar quarter. The option vests as to 25% of the underlying shares of common stock on January 26, 2024, and thereafter at a rate of 6.25% of the underlying shares on the first day of each calendar quarter. Exit Form 4 filed solely to report the Reporting Person is no longer an officer of the Issuer within the meaning of Rule 16a-1 of the Securities Exchange Act of 1934, as amended. /s /Allan Reine, M.D., Attorney-in-Fact 2023-09-13